Selected research
Market Structure
Global Prescription Gastrointestinal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Prescription Gastrointestinal Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Prescription Gastrointestinal Drugs include Eisai, Merck, GlaxoSmithKline, AstraZeneca, Salix Pharmaceuticals and Axcan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Prescription Gastrointestinal Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Prescription Gastrointestinal Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Prescription Gastrointestinal Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prescription Gastrointestinal Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Prescription Gastrointestinal Drugs Segment by Company
Eisai
Merck
GlaxoSmithKline
AstraZeneca
Salix Pharmaceuticals
Axcan Pharmaceuticals
Prescription Gastrointestinal Drugs Segment by Type
Oral
Topical
Prescription Gastrointestinal Drugs Segment by Application
Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Prescription Gastrointestinal Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Gastrointestinal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prescription Gastrointestinal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Gastrointestinal Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Prescription Gastrointestinal Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prescription Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Gastrointestinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prescription Gastrointestinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Topical
Applications
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Companies covered
- Eisai
- Merck
- GlaxoSmithKline
- AstraZeneca
- Salix Pharmaceuticals
- Axcan Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Prescription Gastrointestinal Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Prescription Gastrointestinal Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Prescription Gastrointestinal Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Prescription Gastrointestinal Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Prescription Gastrointestinal Drugs Market Dynamics
- 2.1 Prescription Gastrointestinal Drugs Industry Trends
- 2.2 Prescription Gastrointestinal Drugs Industry Drivers
- 2.3 Prescription Gastrointestinal Drugs Industry Opportunities and Challenges
- 2.4 Prescription Gastrointestinal Drugs Industry Restraints
3 Prescription Gastrointestinal Drugs Market by Manufacturers
- 3.1 Global Prescription Gastrointestinal Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Prescription Gastrointestinal Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Prescription Gastrointestinal Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Prescription Gastrointestinal Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Prescription Gastrointestinal Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Prescription Gastrointestinal Drugs Manufacturers, Product Type & Application
- 3.7 Global Prescription Gastrointestinal Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Prescription Gastrointestinal Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Prescription Gastrointestinal Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Prescription Gastrointestinal Drugs Tier 1, Tier 2, and Tier 3
4 Prescription Gastrointestinal Drugs Market by Type
- 4.1 Prescription Gastrointestinal Drugs Type Introduction
- 4.1.1 Oral
- 4.1.2 Topical
- 4.2 Global Prescription Gastrointestinal Drugs Sales by Type
- 4.2.1 Global Prescription Gastrointestinal Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Prescription Gastrointestinal Drugs Sales by Type (2021-2032)
- 4.2.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Prescription Gastrointestinal Drugs Revenue by Type
- 4.3.1 Global Prescription Gastrointestinal Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Prescription Gastrointestinal Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2021-2032)
5 Prescription Gastrointestinal Drugs Market by Application
- 5.1 Prescription Gastrointestinal Drugs Application Introduction
- 5.1.1 Online Pharmacies
- 5.1.2 Hospital Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Prescription Gastrointestinal Drugs Sales by Application
- 5.2.1 Global Prescription Gastrointestinal Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Prescription Gastrointestinal Drugs Sales by Application (2021-2032)
- 5.2.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Prescription Gastrointestinal Drugs Revenue by Application
- 5.3.1 Global Prescription Gastrointestinal Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Prescription Gastrointestinal Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2021-2032)
6 Global Prescription Gastrointestinal Drugs Sales by Region
- 6.1 Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Prescription Gastrointestinal Drugs Sales by Region (2021-2032)
- 6.2.1 Global Prescription Gastrointestinal Drugs Sales by Region (2021-2026)
- 6.2.2 Global Prescription Gastrointestinal Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Prescription Gastrointestinal Drugs Revenue by Region
- 7.1 Global Prescription Gastrointestinal Drugs Revenue by Region
- 7.1.1 Global Prescription Gastrointestinal Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Prescription Gastrointestinal Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Prescription Gastrointestinal Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Prescription Gastrointestinal Drugs Revenue (2021-2032)
- 7.2.2 North America Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Prescription Gastrointestinal Drugs Revenue (2021-2032)
- 7.3.2 Europe Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Prescription Gastrointestinal Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Prescription Gastrointestinal Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Eisai
- 8.1.1 Eisai Company Information
- 8.1.2 Eisai Business Overview
- 8.1.3 Eisai Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Eisai Prescription Gastrointestinal Drugs Product Portfolio
- 8.1.5 Eisai Recent Developments
- 8.2 Merck
- 8.2.1 Merck Company Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck Prescription Gastrointestinal Drugs Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 GlaxoSmithKline
- 8.3.1 GlaxoSmithKline Company Information
- 8.3.2 GlaxoSmithKline Business Overview
- 8.3.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio
- 8.3.5 GlaxoSmithKline Recent Developments
- 8.4 AstraZeneca
- 8.4.1 AstraZeneca Company Information
- 8.4.2 AstraZeneca Business Overview
- 8.4.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio
- 8.4.5 AstraZeneca Recent Developments
- 8.5 Salix Pharmaceuticals
- 8.5.1 Salix Pharmaceuticals Company Information
- 8.5.2 Salix Pharmaceuticals Business Overview
- 8.5.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
- 8.5.5 Salix Pharmaceuticals Recent Developments
- 8.6 Axcan Pharmaceuticals
- 8.6.1 Axcan Pharmaceuticals Company Information
- 8.6.2 Axcan Pharmaceuticals Business Overview
- 8.6.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
- 8.6.5 Axcan Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Prescription Gastrointestinal Drugs Value Chain Analysis
- 9.1.1 Prescription Gastrointestinal Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Prescription Gastrointestinal Drugs Production Mode & Process
- 9.2 Prescription Gastrointestinal Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Prescription Gastrointestinal Drugs Distributors
- 9.2.3 Prescription Gastrointestinal Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst